Circulating Tumor Cells as a Prognostic Factor of ADT Responsiveness in Survivors With Hormone Naive Metastatic Prostate Cancer
When we make treatment decisions we never know how effective the treatment will actually be for each individual and for how long that treatment effect might last. This makes all of our treatment decisions guess work. A recent study has demonstrated that counting circulating tumor cells in the blood can be used to predict prostate [...]